Elanco has announced the results of a survey it conducted amongst European dermatology diplomates which found that nearly 90% of them consider Comfortis (spinosad) is the first choice of flea control for cats and dogs.

The research was conducted at the…

Elanco Animal Health, maker of Comfortis, Trifexis and Atopica, has launched ScratchTracker, a smartphone app designed to help dog owners with a simple way to monitor pruritus in their pet and share the results with their vet.

Elanco says ScratchTracker…

Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.

The Atopica Comfort Club loyalty scheme now…

Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.

According to the company, compliance with daily ear drops has been shown to be poor, with up…

Leading veterinary dermatologist Sue Paterson has raised concerns that veterinary surgeons are not prioritising pain relief in otitis externa (OE) cases, in a new series of videos commissioned by Elanco Animal Health for Osurnia Gel.

Sue, an RCVS and European…

Elanco Animal Health has launched the Osurnia Ear Health Hub, a canine otitis externa information and support resource for veterinary professionals.

The Osurnia Ear Health Hub includes information about the treatment of canine otitis externa from dermatologists…

Elanco has launched Zenrelia (ilunocitinib), a once-daily tablet for pruritic dogs with atopic dermatitis, flea allergy dermatitis, food allergies and contact allergies, which the company claims is 45% more effective than Apoquel.

Zenrelia is a new JAK in…